Bafna Pharmaceuticals Ltd (BAFNAPH) — Voting Results | 11 September 2026

11 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

31st AGM resolutions passed with requisite majority

💡 Investor Takeaway

Shareholders approved key governance and financial items, reinforcing board continuity and auditor remuneration without dissent.

Bafna Pharmaceuticals held its 31st AGM on September 11, 2026, where shareholders approved the adoption of audited financial statements for FY2026, the reappointment of Director Upendar Mekala Reddy, and the ratification of cost auditor remuneration. All resolutions passed with requisite majority under ordinary voting. Voting was conducted via e-voting and video conference, with 1,81,58,531 votes cast in favor across resolutions and negligible dissent. The company confirmed compliance with SEBI LODR disclosure norms.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BAFNAPH ✨ Ask AI About This

About Bafna Pharmaceuticals Ltd (BAFNAPH)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹875.99 Cr

View full BAFNAPH stock details →

📡 Get AI alerts when BAFNAPH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BAFNAPH — Free

💡 Ask AI about this filing

"What is the impact of auditor remuneration approval on future audit fees?""How does the 99.99% voting outcome affect board composition stability?""What is the company's dividend policy following FY2026 results?"

Ask AI Free →

📊 More BAFNAPH filings

Announcement — 26 September 2026Bafna Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain sh...
🔴 Annual Report — 19 August 2026Bafna Pharmaceuticals Limited announced its 31st Annual General Meeting (AGM) to be held on Septembe...
🟡 Board Meeting — 13 August 2026Bafna Pharmaceuticals announced its 31st Annual General Meeting will be held on September 11, 2026, ...
🟡 Board Meeting — 13 August 2026Bafna Pharmaceuticals announced its 31st Annual General Meeting will be held on September 11, 2026 v...
🟡 Board Meeting — 11 August 2026Bafna Pharmaceuticals announced the outcome of its August 11, 2026 board meeting, approving unaudite...

See all BAFNAPH filings →

🔥 Also filed on 11 September 2026

MONEYBOXXMoneyboxx Finance LtdInsider Trading ADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncement 517170Edvenswa Enterprises LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement SIGMAADVSigma Advanced System LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BAFNAPH files new disclosures

Track BAFNAPH filings, board meetings, and corporate actions. Free email alerts at 5 PM.